Just a guess (plus the cash)... we will see when they hold a conference call in a few weeks. When you say "whole company," we aren't talking about a huge enterprise. Deal closes quickly.
from PR:
"Eximias employs a seasoned management team and has cash resources in excess of $30M"
"The current management team of YM BioSciences will remain in place and expanded to include senior members of the Eximias management team in Clinical, Regulatory, Marketing, Manufacturing and Corporate Development."
"Illegitimacy is something we should talk about in terms of not having it."
- Dan Quayle